Market revenue in 2024 | USD 131.8 million |
Market revenue in 2030 | USD 188.2 million |
Growth rate | 5.8% (CAGR from 2025 to 2030) |
Largest segment | Breast cancer |
Fastest growing segment | Breast Cancer |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer |
Key market players worldwide | Abbott Laboratories, Bayer AG, Agilent Technologies Inc, Danaher Corp, Hologic Inc, Qiagen NV, Siemens AG, Sysmex Corp, Becton Dickinson & Co, Roche Holding AG ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oncology based molecular diagnostics market will help companies and investors design strategic landscapes.
Breast cancer was the largest segment with a revenue share of 20.79% in 2024. Horizon Databook has segmented the Middle East & Africa oncology based molecular diagnostics market based on breast cancer, prostate cancer, colorectal cancer, cervical cancer, liver cancer, lung cancer, blood cancer, kidney cancer covering the revenue growth of each sub-segment from 2018 to 2030.
MEA includes South Africa and Saudi Arabia. Economic development and presence of high unmet healthcare needs witnessed in the emerging markets such as in South Africa are primary growth drivers of this market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa oncology based molecular diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa oncology based molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account